Efficacy of Nebulised Hypertonic Saline (3%) Among Children With Bronchiolitis.
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of nebulized 3% hypertonic saline in improving clinical severity
scores among children aged 6 weeks to 24 months with bronchiolitis.